A study of MCLA-158 in the treatment of colorectal cancer
Phase of Trial: Phase I/II
Latest Information Update: 28 Apr 2017
At a glance
- Drugs MCLA 158 (Primary)
- Indications Acute myeloid leukaemia; Cancer; Colorectal cancer; Multiple myeloma; Solid tumours
- Focus Adverse reactions; First in man
- 28 Apr 2017 According to a Merus media release, company expects to file a CTA for this trial by the end of 2017.
- 03 Jun 2016 New trial record
- 01 Jun 2016 According to a Merus media release, the company plans to file an Investigational New Drug Application (IND) with the FDA by the end of year 2017.